Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN105755066B details a green enzymatic route for chiral dihydrothiophenes. Discover cost-effective manufacturing and supply chain advantages for pharmaceutical intermediates.
Novel water-phase synthesis route for tetrazoleacetic acid reduces waste and cost. Ideal for pharmaceutical intermediates supply chain optimization and green manufacturing compliance.
Patent CN101824438B details microbial synthesis of high-purity (S)-EHB using yeast. Offers cost-effective, scalable pharmaceutical intermediate solutions.
Patent CN110862324A discloses a novel iridium-catalyzed asymmetric reductive amination method achieving up to 95% ee for key pharmaceutical intermediates like Cinacalcet.
Novel patent CN115974802B details high-yield synthesis. Reduces temperature and impurities for reliable pharmaceutical intermediates supply chain stability.
Patent CN115340494A reveals a novel 3-step route for high-purity aripiprazole. Discover cost-effective manufacturing and supply chain advantages for pharma intermediates.
Novel Grignard-based route for Crisborole eliminates Palladium, reducing cost and improving supply chain reliability for pharmaceutical intermediates.
Novel method for high-purity iloperidone preparation reduces impurities and enhances supply chain reliability for global pharmaceutical manufacturing partners seeking cost efficiency.
Novel synthesis of p-hydroxy penicillin V acid ensures high purity. Reduces costs in antibiotics manufacturing and improves supply chain reliability for global buyers.
Patent CN113816882B details a novel one-pot dehydration method using Selectfluor and NaI, offering a safer, high-yield alternative to toxic POCl3 processes for pharmaceutical intermediates.
Novel patent CN117105883B enables high-purity buffer production with reduced waste and simplified purification for pharmaceutical applications ensuring supply chain reliability.
Novel oxidation method for Tenofovir intermediate ensures high purity and yield. Offers significant cost reduction and supply chain reliability for API manufacturing partners globally.
Novel solvent-free method for Tolfenamic Acid synthesis. High yield, reduced cost, scalable production for global pharmaceutical supply chains and reliable API sourcing.
Patent CN112724107A reveals a green dehydration route for alpha-oxo-2-furyl acetic acid from 2-keto-sugar acids, offering a safer alternative for cefuroxime intermediate manufacturing.
Novel method using Cefotaxime and TMSBr offers high yield and cost efficiency for 4th gen cephalosporin production, ensuring reliable supply chain stability.
Patent CN104193601A reveals a safer one-pot oxidation-dehydration route for 3-methyl-2-penten-4-yn-1-al, offering significant cost reduction and supply chain reliability for vitamin A precursors.
Patent CN103755665A reveals a green catalytic method for 3,4-epoxycarane. Achieve high purity and yield with reduced safety risks for fragrance manufacturing.
Patent CN107032971B reveals a mild acid-catalyzed route for 3,7-dimethyl-6-carbonyl-2-octenal, offering significant cost reduction and simplified supply chain operations for fine chemical manufacturing.
Novel chemical resolution method for 1-R-3-fluoropiperidine-4-carboxylic acid replacing expensive chromatography with scalable Mitsunobu esterification.
Patent CN112110840A details a room-temperature LiAlH4 reduction route. Offers high purity and simplified workflow for reliable fragrance intermediate supply chains.